1. 诱导疾病模型产品 Epigenetics TGF-beta/Smad Immunology/Inflammation NF-κB
  2. 免疫与炎症疾病模型 皮肤疾病模型 PKC SphK NF-κB
  3. 皮炎模型
  4. Phorbol 12-myristate 13-acetate

Phorbol 12-myristate 13-acetate  (Synonyms: 佛波酯; PMA; TPA; Phorbol myristate acetate)

目录号: HY-18739 纯度: 99.80%
COA 产品使用指南

Phorbol 12-myristate 13-acetate (PMA) 是一种佛波酯,是蛋白激酶 C (PKC)SphK 的激活剂。Phorbol 12-myristate 13-acetate 是 NF-κB 激活剂。Phorbol 12-myristate 13-acetate 可诱导 THP-1 细胞分化 (已经经过 MCE 专业的生物实验验证)。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Phorbol 12-myristate 13-acetate Chemical Structure

Phorbol 12-myristate 13-acetate Chemical Structure

CAS No. : 16561-29-8

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 价格 是否有货 数量
10 mM * 1 mL in DMSO ¥2171
In-stock
1 mg ¥550
In-stock
5 mg ¥1600
In-stock
10 mg ¥2700
In-stock
50 mg   询价  
100 mg   询价  

* Please select Quantity before adding items.

MCE活性验证

以上结果经由 MCE 实验室检测获得。

MCE 顾客使用本产品发表的 341 篇科研文献

WB

    Phorbol 12-myristate 13-acetate purchased from MCE. Usage Cited in: Pharmacol Res. 2019 Apr;142:1-13.  [Abstract]

    Total lysates from cells are analyzed for the expression of MMP-2 and MMP-9 by Western blot analysis in the treatment of different concentrations of PMA and PDD.

    Phorbol 12-myristate 13-acetate purchased from MCE. Usage Cited in: Pharmacol Res. 2019 Apr;142:1-13.  [Abstract]

    MDA-MB-231 cells are pretreated with PPD for 24 h followed by exposure to 50 ng/mL of PMA for 30 min. The whole cell lysates are analyzed by Western blot for the activation of MAPK.

    Phorbol 12-myristate 13-acetate purchased from MCE. Usage Cited in: Front Mol Neurosci. 2017 Aug 7;10:247.  [Abstract]

    Bar graphs show levels of GABAAR-α2 mRNA and GABAAR-α2 protein in BLA of control mice treated with BLA-injection of H89 or GF109203X (GFX); in MPTP-mice treated with BLA-injection of PMA, or the co-administration of quinpirole and H89 (quin/+H89) or GF109203X (quin/+GFX).
    • 生物活性

    • 实验参考方法

    • 纯度 & 产品资料

    • 参考文献

    生物活性

    Phorbol 12-myristate 13-acetate (PMA), a phorbol ester, is a dual SphK and protein kinase C (PKC) activator[1][2]. Phorbol 12-myristate 13-acetate is a NF-κB activator. Phorbol 12-myristate 13-acetate induces differentiation in THP-1 cells[3][7].

    IC50 & Target[1][7]

    PKC

    11.7 nM (EC50)

    NF-κB

     

    细胞效力
    (Cellular Effect)
    Cell Line Type Value Description References
    MT4 EC50
    0.7 nM
    Compound: 13
    Antiviral activity against HIV2 ROD infected in MT4 cells assessed as cell viability after 5 days by MTT assay
    Antiviral activity against HIV2 ROD infected in MT4 cells assessed as cell viability after 5 days by MTT assay
    [PMID: 25970561]
    MT4 EC50
    0.9 nM
    Compound: 13
    Antiviral activity against HIV1 3B infected in MT4 cells assessed as cell viability after 5 days by MTT assay
    Antiviral activity against HIV1 3B infected in MT4 cells assessed as cell viability after 5 days by MTT assay
    [PMID: 25970561]
    SNU-387 IC50
    > 10 μM
    Compound: 10
    Cytotoxicity against human SNU387 cells after 48 hrs by MTT assay
    Cytotoxicity against human SNU387 cells after 48 hrs by MTT assay
    [PMID: 23701597]
    U-937 EC50
    0.45 nM
    Compound: PMA
    Induction of attachment of U937 cells after 48 hrs
    Induction of attachment of U937 cells after 48 hrs
    [PMID: 17284021]
    Vero EC50
    > 162 μM
    Compound: 4, TPA
    Antiviral activity against Semliki forest virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect incubated for 6 to 7 days by MTS assay
    Antiviral activity against Semliki forest virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect incubated for 6 to 7 days by MTS assay
    [PMID: 23215460]
    Vero EC50
    0.0029 μM
    Compound: 4, TPA
    Antiviral activity against Chikungunya virus 899 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect incubated for 6 to 7 days by MTS assay
    Antiviral activity against Chikungunya virus 899 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect incubated for 6 to 7 days by MTS assay
    [PMID: 23215460]
    Vero EC50
    2.2 μM
    Compound: 4, TPA
    Antiviral activity against Sindbis virus HRsp infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect incubated for 6 to 7 days by MTS assay
    Antiviral activity against Sindbis virus HRsp infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect incubated for 6 to 7 days by MTS assay
    [PMID: 23215460]
    Vero EC50
    2.9 nM
    Compound: 13
    Antiviral activity against chikungunya virus Indian ocean strain 899 infected in Vero cells assessed as virus-induced cytopathic effect after 6 to 7 days
    Antiviral activity against chikungunya virus Indian ocean strain 899 infected in Vero cells assessed as virus-induced cytopathic effect after 6 to 7 days
    [PMID: 25970561]
    Vero CC50
    5.7 μM
    Compound: 4, TPA
    Cytotoxicity against african green monkey Vero cells by MTS assay
    Cytotoxicity against african green monkey Vero cells by MTS assay
    [PMID: 23215460]
    Vero CC50
    5.7 μM
    Compound: TPA
    Cytotoxicity against African green monkey Vero cells assessed as morphological changes by microscopic method
    Cytotoxicity against African green monkey Vero cells assessed as morphological changes by microscopic method
    [PMID: 28925702]
    体外研究
    (In Vitro)

    PMA (100, 200 ng/mL;1-5 天) 诱导 THP-1 细胞孵育分化成巨噬细胞样细胞 (THP-1 巨噬细胞),从而导致形态变化,即贴壁样的巨噬细胞样表型,且细胞表面 CD11b 表达增加[3][5]
    注意事项:
    1. THP-1 倾向于高密度生长,需要偏高的密度维持较好的细胞状态,一般1:2 半换液或者补液来传代,少离心,尽量使用高质量血清。
    2. 传代次数、细胞状态、细胞密度都可能会影响诱导效果。必要时请调整细胞状态至较好时开展实验 (细胞形态饱满,大小均一,折光性较好, 为悬浮生长单个细胞)。
    3. PMA 使用时请注意避光储存 ,配成 DMSO 母液后分装冻存,避免反复冻融。
    4. 如何判断实验成功:最直观的就是细胞由悬浮生长变成贴壁生长。

    PMA (20 ng/mL,36 小时) 通过激活 PKC-δ/Syk/NF-κB 介导的 Thy-1 上调来抑制内皮细胞迁移[8]

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    体内研究
    (In Vivo)

    Phorbol 12-myristate 13-acetate (PMA) 可用于构建耳部水肿和足部水肿模型[8][9]

    1. 诱发耳部水肿[8]
    致病原理
    PMA 可诱导由蛋白激酶 C (PKC) 介导的明显炎症反应,特别是激活 PLA2 来引发炎症。
    具体造模方法:
    小鼠:Swiss 小鼠 • 雌性 • 25-30 g
    给药方式:100 μg/mL • 取 20 μL 局部应用于单耳 • 单剂量
    Note
    造模成功指标
    外观监测:左右耳厚度差异明显增大。
    指标变化:血管通透性增加。
    相关产品: /
    拮抗产品: Hydroxyachillin; Indomethacin (HY-14397)

    2. 诱发足部水肿[9]
    致病原理
    PMA 可诱导由蛋白激酶 C (PKC) 介导的明显炎症反应,特别是激活 PLA2 来引发炎症。
    具体造模方法:
    大鼠:Wistar • 雄性 • 成年大鼠 • 200-220 g
    小鼠:Swiss 白化病 • 雄性 • 25-30 g
    给药方式:Topically applied in one ear • 2.5 μg in 20 μL vehicle • 单剂量
    Note
    其他抑制性产品应在处死小鼠前4小时进行处理。
    造模成功指标
    外观监测:左右耳质量差异明显增大。
    指标变化:刺激巨噬细胞产生超氧阴离子。
    拮抗产品: /

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    分子量

    616.83

    Formula

    C36H56O8

    CAS 号
    性状

    固体

    颜色

    White to off-white

    中文名称

    佛波醇12-十四酸酯13-乙酸酯;(12-)十四酸佛波酯(-13-)乙酸盐;佛波酯

    结构分类
    初始来源
    运输条件

    Room temperature in continental US; may vary elsewhere.

    储存方式

    -20°C, protect from light

    *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

    溶解性数据
    细胞实验: 

    DMSO 中的溶解度 : 100 mg/mL (162.12 mM; 超声助溶; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)

    Ethanol 中的溶解度 : 100 mg/mL (162.12 mM; 超声助溶)

    配制储备液
    浓度 溶剂体积 质量 1 mg 5 mg 10 mg
    1 mM 1.6212 mL 8.1060 mL 16.2119 mL
    5 mM 0.3242 mL 1.6212 mL 3.2424 mL
    查看完整储备液配制表

    * 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
    储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (protect from light)。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

    • 摩尔计算器

    • 稀释计算器

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    质量
    =
    浓度
    ×
    体积
    ×
    分子量 *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    浓度 (start)

    C1

    ×
    体积 (start)

    V1

    =
    浓度 (final)

    C2

    ×
    体积 (final)

    V2

    动物实验:

    请根据您的 实验动物和给药方式 选择适当的溶解方案。

    以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:
    ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用
    以下溶剂前显示的百分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

    • 方案 一

      请依序添加每种溶剂: 10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: ≥ 2.5 mg/mL (4.05 mM); 澄清溶液

      此方案可获得 ≥ 2.5 mg/mL(饱和度未知)的澄清溶液。

      1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;再向上述体系中加入 50 μL Tween-80,混合均匀;然后再继续加入 450 μL 生理盐水 定容至 1 mL

      生理盐水的配制:将 0.9 g 氯化钠,溶解于 ddH₂O 并定容至 100 mL,可以得到澄清透明的生理盐水溶液。
    • 方案 二

      请依序添加每种溶剂: 10% DMSO    90% (20% SBE-β-CD in Saline)

      Solubility: 2.5 mg/mL (4.05 mM); 悬浊液; 超声助溶

      此方案可获得 2.5 mg/mL的均匀悬浊液,悬浊液可用于口服和腹腔注射。

      1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液 中,混合均匀。

      2 g SBE-β-CD(磺丁基醚 β-环糊精)粉末定容于 10 mL 的生理盐水中,完全溶解至澄清透明。
    动物溶解方案计算器
    请输入动物实验的基本信息:

    给药剂量

    mg/kg

    动物的平均体重

    g

    每只动物的给药体积

    μL

    动物数量

    由于实验过程有损耗,建议您多配一只动物的量
    请输入您的动物体内配方组成:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    如果您的动物是免疫缺陷鼠或者体弱鼠,建议 DMSO 中的在最后工作液体系中的占比尽量不超过 2%。
    方案所需 助溶剂 包括:DMSO ,均可在 MCE 网站选购。 Tween 80,均可在 MCE 网站选购。
    计算结果
    工作液所需浓度 : mg/mL
    储备液配制方法 : mg 药物溶于 μL  DMSO(母液浓度为 mg/mL)。

    *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

    您所需的储备液浓度超过该产品的实测溶解度,以下方案仅供参考,如有需要,请与 MCE 中国技术支持联系。
    动物实验体内工作液的配制方法 : 取 μL DMSO 储备液,加入 μL  μL ,混合均匀至澄清,再加 μL Tween 80,混合均匀至澄清,再加 μL 生理盐水
    连续给药周期超过半月以上,请谨慎选择该方案。
    请确保第一步储备液溶解至澄清状态,从左到右依次添加助溶剂。您可采用超声加热 (超声清洗仪,建议频次 20-40 kHz),涡旋吹打等方式辅助溶解。
    纯度 & 产品资料

    纯度: 99.80%

    参考文献
    Cell Assay
    [2]

    αT3-1 and LβT-2 cells are grown in monolayer cultured in DMEM in humidified incubator 5% CO2 at 37°C. Serum starvation is with 0.1% FCS in the same medium for 16 h. GnRH and PMA are then added for the length of time as indicated. In general, αT3-1 cells are transiently transfected by ExGen 500 or by jetPRIME, while LβT2 cells only by jetPRIME transfection reagent. For experiments with dominant-negative (DN) PKCs, αT3-1 cells (in 6 cm plates) are transfected with 1.5 μg of p38α-GFP with 3 μg of control vector, pCDNA3, or with 3 μg of the DN-PKCs constructs. For LβT2 cells, transfections are performed (in 10 cm plates) with 4 μg of p38α-GFP along with 9 μg of control vector, pCDNA3, or with 9 μg of the DN-PKCs constructs. Approximately 30 h after transfection, the cells are serum starved (0.1% FCS) for 16 h and later stimulated with GnRH or PMA, washed twice with ice-cold PBS, treated with the lysis buffer, followed by one freeze-thaw cycle. Cells are harvested; following centrifugation (15,000×g, 15 min, 4°C) supernatants are taken for immunoprecipitation experiments[2].

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Administration
    [3]

    Rats[3]
    All experiments qre performed with male Wistar rats (weighing 250-280 g). One hundred and thirty-five Wistar rats are randomly divided into seven groups. (1) Rats in the sham group (n=21) are given a lateral cerebral ventricle injection of 0.9% normal saline; (2) Rats in the IR group (n=21) are given a lateral cerebral ventricle injection of 0.9% normal saline 30 min before middle cerebral artery occlusion (MCAO); (3) Rats in the Carbenoxolone (CBX) group (n=21) are given a lateral cerebral ventricle injection of CBX (5 μg/mL×10 μL) 30 min before MCAO; (4) Rats in the Sch-6783 group (n=21) are given a lateral cerebral ventricle injection of DZX (2 mM×30 μL) 30 min prior to MCAO; (5) Rats in the 5-HD group (n=21) are given a lateral cerebral ventricle injection of 5-HD (100 mM×10 μL), and after 10 min, DZX is injected 15 min prior to MCAO; (6) The rats in the DZX + Ro group (n=15) are given a lateral cerebral ventricle injection of DZX, and after 10 min, Ro-31-8425 (400 μg/kg) is injected 15 min prior to MCAO; (7) The rats in the 5-HD+PMA group (n=15) are given an intraperitoneal injection of PMA (200 μg/kg) after the injection of 5-HD and DZX.

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    参考文献

    完整储备液配制表

    * 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
    储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (protect from light)。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

    可选溶剂 浓度 溶剂体积 质量 1 mg 5 mg 10 mg 25 mg
    DMSO / Ethanol 1 mM 1.6212 mL 8.1060 mL 16.2119 mL 40.5298 mL
    5 mM 0.3242 mL 1.6212 mL 3.2424 mL 8.1060 mL
    10 mM 0.1621 mL 0.8106 mL 1.6212 mL 4.0530 mL
    15 mM 0.1081 mL 0.5404 mL 1.0808 mL 2.7020 mL
    20 mM 0.0811 mL 0.4053 mL 0.8106 mL 2.0265 mL
    25 mM 0.0648 mL 0.3242 mL 0.6485 mL 1.6212 mL
    30 mM 0.0540 mL 0.2702 mL 0.5404 mL 1.3510 mL
    40 mM 0.0405 mL 0.2026 mL 0.4053 mL 1.0132 mL
    50 mM 0.0324 mL 0.1621 mL 0.3242 mL 0.8106 mL
    60 mM 0.0270 mL 0.1351 mL 0.2702 mL 0.6755 mL
    80 mM 0.0203 mL 0.1013 mL 0.2026 mL 0.5066 mL
    100 mM 0.0162 mL 0.0811 mL 0.1621 mL 0.4053 mL
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    您最近查看的产品:

    Your information is safe with us. * Required Fields.

       产品名称:

     

    * 需求量:

    * 客户姓名:

     

    * Email:

    * 电话:

     

    * 公司或机构名称:

       留言给我们:

    Bulk Inquiry

    Inquiry Information

    产品名称:
    Phorbol 12-myristate 13-acetate
    目录号:
    HY-18739
    需求量: